News

18.12.2025

Defining the Best Patient Group for IMMUTOL’s New Cell Therapy: MS Patients Speak Out 

On 25 November 2025, European Multiple Sclerosis Platform (EMSP) organised a consultation between the Multiple Sclerosis Community Advisory Board (MSCAB),…

Nose-to-Brain-Patch Final Outcomes

29.09.2021

Effective drugs for the treatment of diseases of the central nervous system such as multiple sclerosis do exist. However, the…